Press Release

<< Back

Xenon Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference

April 4, 2022

BURNABY, British Columbia, April 04, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that management will participate in one-on-one investor meetings and a fireside chat at the 21st Annual Needham (Virtual) Healthcare Conference.

Fireside Chat Details:

Date: Monday, April 11, 2022
Time: 10:15-10:55 am Eastern Time
Presenters: Ian Mortimer, President and CEO; Sherry Aulin, Chief Financial Officer

Details on company presentations and webcasts can be found on the “Investors” section of Xenon’s website at When available, webcasts will be posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353

Primary Logo

Source: Xenon Pharmaceuticals Inc.